Bake or Die is a fun zombie survival experience that somewhat resembles the likes of Dead Rail, so players coming over from ...

Having trouble with the lengthy Terra Dome of Pragmata? Here's our complete walkthrough for Sector 3, and how to free Eight.

Improving in golf isn’t usually about completely changing your swing. Consistency in the fundamentals is what ultimately lowers scores and separates good golfers from great ones. If you’re looking to ...

TOLEDO, Ohio (WTVG) - A lot of us enjoy a good scare. Well, there’s a horrifying place in downtown Toledo made just for you. We saddle up and take you to The Pale Horse in this week’s Hittin’ the Town ...

Takeda has posted phase 3 data on an autoimmune asset it acquired for $4 billion, laying down a marker ahead of a fight for market share with companies including Bristol Myers Squibb and Johnson & ...

Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...

Human verification ‘will be rare and will not apply to most users,’ according to Reddit CEO Steve Huffman. Human verification ‘will be rare and will not apply to most users,’ according to Reddit CEO ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting progress for the botensilimab ...

LEXINGTON, Mass.--(BUSINESS WIRE)--$AGEN #BOT--Agenus Inc. (Nasdaq: AGEN) today reported financial results for the fourth quarter and full year ended December 31 ...

I couldn’t get past the uncanny valley of looking at an AI avatar listening to my answers. I couldn’t get past the uncanny valley of looking at an AI avatar listening to my answers. is The Verge’s ...

The biggest stories of the day delivered to your inbox.

Agenus Inc. (NASDAQ:AGEN) is one of the most undervalued penny stocks to buy right now. On February 19, Agenus presented new translational and clinical biomarker data from its Phase 1b C-800-01 trial, ...